Clinical characteristics and prognostic implications in patients with HER2-low breast cancer undergoing neoadjuvant chemotherapy: a retrospective cohort study

被引：0
|
作者：
Zheng, Ang [1 ]
He, Junlin [2 ]
Li, Muyao [1 ]
Yao, Fan [1 ]
Jin, Feng [1 ]
Chen, Bo [1 ]
Wang, Xin [2 ]
机构：
[1] China Med Univ, Hosp 1, Shenyang, Peoples R China
[2] China Med Univ, Shenyang, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
HER2; Low; Breast Cancer;
D O I：
10.1016/j.lanwpc.2024.101378
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, S.
    Lee, S. H.
    Lee, H. J.
    Jeong, H.
    Jeong, J-H.
    Kim, J. E.
    Ahn, J-H.
    Jung, K. H.
    Kim, H. H.
    Lee, S.
    Lee, J.
    Kim, S-B.
    ANNALS OF ONCOLOGY, 2023, 34 : S305 - S305
  • [2] Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer
    Kang, Sora
    Lee, So Heun
    Lee, Hee Jin
    Jeong, Hyehyun
    Jeong, Jae Ho
    Kim, Jeong Eun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Gong, Gyungyub
    Kim, Hak Hee
    Lee, Saebyeol
    Lee, Jongwon
    Kim, Sung-Bae
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [3] Clinical outcomes of neoadjuvant chemotherapy in HER2-low early breast cancer
    Gudelj, Dora
    Cular, Katarina
    Toula, Lea
    Krizic, Marija
    Popovic, Marina
    Plavetic, Natalija Dedic
    Kelecic, Ana
    Ivanac, Gordana
    Soce, Majana
    Gjergjaj, Iva Kukal
    Silovski, Tajana
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Tumor characteristics and survival rate of HER2-low breast cancer patients: a retrospective cohort study
    Abbasvandi, Fereshteh
    Bayat, Mahdis
    Akbari, Atieh
    Shojaeian, Fatemeh
    Zandi, Ashkan
    Rahmani, Jamal
    Hashemi, Maryam Omrani
    Akbari, Mohammad Esmaeil
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [5] Tumor characteristics and survival rate of HER2-low breast cancer patients: a retrospective cohort study
    Fereshteh Abbasvandi
    Mahdis Bayat
    Atieh Akbari
    Fatemeh Shojaeian
    Ashkan Zandi
    Jamal Rahmani
    Maryam Omrani Hashemi
    Mohammad Esmaeil Akbari
    Scientific Reports, 13 (1)
  • [6] Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis
    Yingbo Shao
    Yang Yu
    Zhifen Luo
    Huijuan Guan
    Fangyuan Zhu
    Yaning He
    Qi Chen
    Chaojun Liu
    Bing Nie
    Hui Liu
    Annals of Surgical Oncology, 2022, 29 : 8026 - 8034
  • [7] Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis
    Shao, Yingbo
    Yu, Yang
    Luo, Zhifen
    Guan, Huijuan
    Zhu, Fangyuan
    He, Yaning
    Chen, Qi
    Liu, Chaojun
    Nie, Bing
    Liu, Hui
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (13) : 8026 - 8034
  • [8] Clinical, pathological complete response and prognosis characteristics of HER2-low breast cancer in neoadjuvant chemotherapy setting: A retrospective analysis
    Liu, H.
    Yu, Y.
    Luo, Z.
    Zhu, F.
    He, Y.
    Chen, Q.
    Liu, C.
    Shao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1436 - S1436
  • [9] HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study
    Baez-Navarro, Ximena
    van Bockstal, Mieke R.
    Jager, Agnes
    van Deurzen, Carolien H. M.
    PATHOLOGY, 2024, 56 (03) : 334 - 342
  • [10] Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Man Yang
    Jiale Sun
    Liqiong Liu
    Xiangyi Kong
    Dongcai Lin
    Hong Zhou
    Jidong Gao
    Scientific Reports, 13 (1)
12345